3-Isoxazolamine → 1-Isoxazol-3-yl-4-(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)piperazine
반응식
[Cl:1][CH2:2][CH2:3][N:4]([c:5]1[c:6]([CH3:18])[c:7]([CH3:17])[c:8]2[c:9]([c:15]1[CH3:16])[CH2:10][C:11]([CH3:13])([CH3:14])[O:12]2)[CH2:19][CH2:20][Cl:21].[o:22]1[n:23][c:24]([NH2:27])[cH:25][cH:26]1>>[CH2:2]1[CH2:3][N:4]([c:5]2[c:6]([CH3:18])[c:7]([CH3:17])[c:8]3[c:9]([c:15]2[CH3:16])[CH2:10][C:11]([CH3:13])([CH3:14])[O:12]3)[CH2:19][CH2:20][N:27]1[c:24]1[n:23][o:22][cH:26][cH:25]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-e521eb6139ae463fabc146c48a1a2823
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (4/10)
반응 노트
불러오는 중…